Literature DB >> 31075687

Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy.

Biswadeep Nayak1, Gowri Manohari Balachander2, Sathish Manjunath3, Annapoorni Rangarajan4, Kaushik Chatterjee5.   

Abstract

Breast cancer cell lines lose the inherent gene expression profiles of their source tumor and when cultured as monolayers (two-dimensional) are unable to represent patient tumors. Thus, we engineered a biochemico- and mechano-mimetic three-dimensional (3D) culture platform for primary breast cancer cells by decellularizing cancer-associated fibroblasts (CAFs) cultured on 3D macroporous polymer scaffolds to recapitulate tumor behavior and drug response more realistically. The presence of the CAF-derived extracellular matrix deposited on the polycaprolactone scaffold promoted cell attachment and viability, which is ascribed to higher levels of phosphorylated Focal Adhesion Kinase that mediates cell attachment via integrins. Single cells from primary breast cancers self-organized into tumoroids on prolonged culture. Response of the tumoroids to two chemotherapeutic drugs, doxorubicin and mitoxanthrone, varied significantly across patient samples. This model could be used as an ex vivo platform to culture primary cells toward developing effective and personalized chemotherapy regimens.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D culture; Breast cancer; Cancer associated fibroblasts; Organoids; Personalized medicine

Mesh:

Substances:

Year:  2019        PMID: 31075687     DOI: 10.1016/j.colsurfb.2019.04.056

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  9 in total

Review 1.  Addressing Patient Specificity in the Engineering of Tumor Models.

Authors:  Laura J Bray; Dietmar W Hutmacher; Nathalie Bock
Journal:  Front Bioeng Biotechnol       Date:  2019-09-12

2.  Tissue density in the progression of breast cancer: Bedside to bench and back again.

Authors:  Emily Fabiano; Jian Zhang; Cynthia A Reinhart-King
Journal:  Curr Opin Biomed Eng       Date:  2022-03-28

Review 3.  Decellularization of tumours: A new frontier in tissue engineering.

Authors:  Elena García-Gareta; María Ángeles Pérez; José Manuel García-Aznar
Journal:  J Tissue Eng       Date:  2022-04-25       Impact factor: 7.940

Review 4.  Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.

Authors:  Jingjing Qu; Farhin Shaheed Kalyani; Li Liu; Tianli Cheng; Lijun Chen
Journal:  Cancer Commun (Lond)       Date:  2021-10-29

Review 5.  Current Status of Breast Organoid Models.

Authors:  Srivarshini Cherukupalli Mohan; Tian-Yu Lee; Armando E Giuliano; Xiaojiang Cui
Journal:  Front Bioeng Biotechnol       Date:  2021-11-05

Review 6.  3D and organoid culture in research: physiology, hereditary genetic diseases and cancer.

Authors:  Elisa Suarez-Martinez; Irene Suazo-Sanchez; Manuel Celis-Romero; Amancio Carnero
Journal:  Cell Biosci       Date:  2022-04-01       Impact factor: 7.133

Review 7.  Three-dimensional in vitro culture models in oncology research.

Authors:  Camille Jubelin; Javier Muñoz-Garcia; Laurent Griscom; Denis Cochonneau; Emilie Ollivier; Marie-Françoise Heymann; François M Vallette; Lisa Oliver; Dominique Heymann
Journal:  Cell Biosci       Date:  2022-09-11       Impact factor: 9.584

8.  Porous Polymeric Microspheres With Controllable Pore Diameters for Tissue Engineered Lung Tumor Model Development.

Authors:  Dinesh Dhamecha; Duong Le; Rachel Movsas; Andrea Gonsalves; Jyothi U Menon
Journal:  Front Bioeng Biotechnol       Date:  2020-07-10

9.  A cancer invasion model of cancer-associated fibroblasts aggregates combined with TGF-β1 release system.

Authors:  Teruki Nii; Kimiko Makino; Yasuhiko Tabata
Journal:  Regen Ther       Date:  2020-03-04       Impact factor: 3.419

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.